Startup Funding News

Mushroom-based materials that can replace leather.

An oral drug candidate for advanced heart failure.

AI models for designing gene and cell therapies.

Loyal develops veterinary medicines intended to extend the healthy lifespan of dogs.

Engine Biosciences combines machine learning with experimental genetics to identify drug targets and biomarkers for precision cancer medicines.

Cellares manufactures cell therapies for biopharmaceutical companies using automated production and quality-control systems designed to replace labor-intensive contract manufacturing.

Merge Labs researches brain-computer interfaces that combine molecular engineering, ultrasound and AI to communicate with neural activity without implants inside brain tissue.

Converge Bio provides AI tools that help biologists discover drug targets, design antibodies and optimize protein sequences for manufacturing, integrating these tasks into existing drug-development workflows.

Clustering antibodies designed to restore impaired cellular signalling.

Bispecific antibodies that remove disease-driving proteins outside cells.

Cell-penetrating peptide medicines targeting proteins involved in cancer.

Cancer treatments combining targeted drugs with laser illumination.

Drug discovery using cellular stress responses, imaging and AI.